10% Owner Opaleye Management Sells $7.8M in Harrow Stock
summarizeSummary
Opaleye Management Inc., a 10% owner of Harrow, Inc., disposed of approximately $7.8 million worth of common stock in open market sales.
check_boxKey Events
-
10% Owner Sells Shares
Opaleye Management Inc., a significant institutional investor and 10% owner of Harrow, Inc., sold 198,572 shares of common stock.
-
Substantial Value Disposed
The total value of the shares sold was approximately $7.85 million, executed in open market transactions on March 3rd and 4th, 2026.
-
Timing Post-Positive News
This sale occurred immediately after Harrow, Inc. reported strong Q4 earnings and initiated a Phase 3 clinical trial, potentially signaling a lack of increased conviction despite recent positive developments.
auto_awesomeAnalysis
This Form 4 filing reports a substantial open market sale of Harrow, Inc. common stock by Opaleye Management Inc., a 10% owner. The disposition of approximately $7.85 million in shares, representing 0.583% of the company's market capitalization, indicates a notable reduction in exposure by a significant institutional investor. While such sales by 10% owners can be for portfolio rebalancing, the timing, just days after the company reported strong Q4 earnings and initiated a Phase 3 clinical trial, could be viewed negatively by the market as it suggests a lack of increased conviction despite recent positive operational developments.
At the time of this filing, HROW was trading at $36.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $20.85 to $54.85. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.